Janus Henderson Group
RIGL icon

Janus Henderson Group’s Rigel Pharmaceuticals RIGL Stock Holding History

Janus Henderson Group’s Portfolio RIGL Stock Details RIGL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$6.54M Buy
2022
Q4 		– Sell
2022
Q3 		$80K Buy
2022
Q2 		$39K Sell
2022
Q1 		$102K Hold
2021
Q4 		$91K Buy
2021
Q3 		$62K Buy